Alkermes
Teva Wins License to Launch Generic Vivitrol in 2027 After Patent Settlement with Alkermes
Anika Sharma
Teva Pharmaceuticals has secured a pivotal victory in a patent dispute settlement with Alkermes, the manufacturer of Vivitrol. This settlement ...
After winning the J&J arbitration dispute, Alkermes, which is close to splitting its oncology business, saw a significant Q2 revenue increase
SG Tylor
Alkermes is feeling confident about its prospects for the second half of 2023, after winning a big arbitration case against ...
